Ethanolamine → 2-[[(3-Chloro-2-fluorophenyl)methyl]thio]4-[(2-hydroxyethyl)amino]-7(8H)-pteridinone
Reaktionsgleichung
Br[C:2]1[C:11]2[N:10]=[CH:9][C:8](=[O:12])[NH:7][C:6]=2[N:5]=[C:4]([S:13][CH2:14][C:15]2[CH:20]=[CH:19][CH:18]=[C:17]([Cl:21])[C:16]=2[F:22])[N:3]=1.[CH2:23]([CH2:25][NH2:26])[OH:24]>>[Cl:21][C:17]1[C:16]([F:22])=[C:15]([CH2:14][S:13][C:4]2[N:3]=[C:2]([NH:26][CH2:25][CH2:23][OH:24])[C:11]3[N:10]=[CH:9][C:8](=[O:12])[NH:7][C:6]=3[N:5]=2)[CH:20]=[CH:19][CH:18]=1Komponenten
3
Versuchsvorschrift
The titled compound (51 mg) was prepared by the method of Example 6, step (f) using the product from Example 6, step (e) (75 mg) and ethanolamine (25 μl).
Quellen und Nachweise
- ORD-Eintrag
- ord-8e625f6983434f6dacf77c3fd110c053
- Quelldatensatz
- uspto-grants-2005_04
- Patentnummer
- US06875868B2
Notizen zur Reaktion
Wird geladen…